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httpcense.Abstract Lung cancer is the most common cause of cancer –related deaths. Chest CT scan is fre-
quently unreliable in staging mediastinal lymph node metastases of lung cancer, since interpretation
relies on lesion size. EBUS offers a unique way of imaging and parabronchial structures. The pro-
cedure is safe, minimally invasive and does not require general anesthesia or hospitalization. The
complication rate is extremely low.
Subjects and methods: This study was conducted on eleven patients who were found without CT
evidence of enlarged mediastinal lymph nodes. Bronchoscopy and EBUS were performed for the
diagnosis of lung cancer. TBLB of detected mediastinal lymph nodes was performed. CT guided
biopsies were done for non-diagnosed cases.
Results: In this study bronchogenic carcinoma was diagnosed by bronchoscopic biopsy in 6
cases (54.5%), by EBUS-TBNA in 2 cases (18.2%), and by CT guided biopsy in 3 cases
(27.3%). From the eleven patients with negative CT scan, EBUS of mediastinal L.N was positive
in four cases (36.4%). The ﬁrst case showed 2 small subcarinal L.N station (7) and 2 right hilar
lymph node stations (10R). In the second case EBUS detected 2 subcarinal lymph node stations
(7) and one left hilar station (10L). In the third case there was one subcarinal lymph node station
(7). The fourth case showed a left hilar lymph node station (10L).
Conclusions: EBUS is safe and minimally invasive technique in the detection of mediastinal
lymph metastasis. EBUS in combination with conventional radiologic tools may contribute to
improve diagnosis and staging of lung cancer.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.trasound; TBLB, Transbronchial lung biopsy; L.N, lymph node; CT, computed tomography
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Lung cancer continues to be a major health problem, it is the
most common cause of cancer-related deaths in men and wo-
men worldwide [4].
Accurate staging in patients with lung cancer is of para-
mount importance. It will guide choices of treatment and
determine prognosis and outcome [2].
Because the mediastinal and hilar lymph nodes are adjacent
to the pulmonary artery or vein, and movement and partial
volume effects of these vessels occur, it is occasionally difﬁcult
to differentiate lymph nodes from vascular structures [7].
Conventional radiologic tools such as chest CT scan and
chest tomography are frequently unreliable in staging medias-
tinal lymph node metastases of lung cancer, with limited diag-
nostic accuracy since interpretation relies principally on lesion
size [14].
The technique of endobronchial ultrasonography (EBUS)
has improved signiﬁcantly in the last years. However, it has
been used in very few studies to determine the mediastinal
and hilar lymph node metastases [8].
EBUS offers a unique way of imaging and parabronchial
structures during a bronchoscopic procedure. The procedure
is safe, minimally invasive and does not require general anes-
thesia or hospitalization. The complication rate is extremely
low [12].
EBUS may be superior to conventional radiologic tools in
the detection of mediastinal and hilar lymph node metastases.
Clinically it should be considered in the staging of all patients
without mediastinal lymph node enlargement on CT scan. It
could be an obvious choice for the primary procedure, to know
whether lymph node metastases are present prior to treatment
in order to improve the accuracy of diagnosis of lymph node
metastases [6].
Subjects and methods
This study was conducted in the Bronchoscopy and Endobron-
chial Ultrasound Unit, chest department, Kasr El-Aini hospi-
tal in the period from December 2007 to 2009. Patients with an
indication for bronchoscopy were screened for the study. Ele-
ven patients who were found without CT evidence of enlarged
mediastinal lymph nodes were enrolled in the current study, (9)
male patients and (2) females. Bronchoscopy and endobron-
chial US were performed for the diagnosis of lung cancer.
TBLB of detected mediastinal lymph nodes was performed
for cytological examination. CT guided biopsies were done
for non diagnosed cases by bronchoscopy.
All patients were subjected to:
1. Thorough history taking and complete physical
examination.
2. Plain chest X-ray PA and lateral views.
3. CT of the chest with contrast.
4. Bronchoscopic examination of the tracheobronchial tree.
Biopsies were taken either endobronchial or TBLB for
the diagnosis of lung cancer.
5. EBUS was performed for all patients through the channel
of the ﬁberoptic bronchoscope for visualization and detec-
tion of mediastinal lymph nodes. TBNA of the detected
nodes was performed for cytological examination.6. CT guided lung biopsy was performed to patients who
could not be diagnosed by bronchoscopic biopsy.
7. Histopathological examination of operative specimens of
mediastinal nodes was recorded if performed.
Conventional bronchoscope procedure
Patient and instrument preparation:
 Patient consent for the technique was obtained after
explaining the procedure to him.
 Patient is asked to fast 6 h for the procedure.
 Decontamination and disinfection were done to the bron-
choscopic instruments and accessories by 2% glutaralde-
hyde at the beginning and end of a list and between the
patients
 Routine investigations were done to the patients in the form
of CBC, blood sugar, liver and kidney functions in addition
to coagulation and clotting proﬁles.
Premedication:
 Patient was given one ampoule atropine intramuscular
0.6 mg about 10 min. before the procedure.
 High ﬂow oxygen was sometimes used specially for elderly
and frail patients via nasal cannulae and the saturation
was continuously monitored via pulse oximetry.
 Pethidine 100 mg was used intravenously about 15 min.
before the procedure to sedate the patient but not all
patients.
 2% lidocaine gel and 2% lidocaine solution were used as
topical anesthesia during the procedure.
The procedure:
 The bronchoscope was well lubricated with 2% lidocaine
gel and passed through the nostril of the patient under
direct vision with the patient lying comfortably in a semi
recumbent position.
 Once the bronchoscope reaches the vocal cords, topical
anesthesia was used in the form of 2% lidocaine through
the suction channel of bronchoscope and the patient was
asked to say ‘‘eeee’’ to see the full opposition of the vocal
cords, then additional 2.5 ml aliquots of 2% lidocaine
(50 mg) were instilled down the suction channel of the bron-
choscope if needed, using boluses from 5 ml syringes made
up to volume with air until the procedure was ﬁnished.
EBUS procedure:
 After introduction of FOB through the airway by all steps
mentioned above a 20-MHz radial mechanical transducer
type ultrasonic probe in a ﬂexible sheet equipped with a bal-
loon at the tip connected to an EBUS processor was
inserted in the channel and used to localize the abnormal
lymph nodes if present and to make precise their relation-
ship with the tracheobronchial tree. It was performed with
the small probe applied directly on the wall, without bal-
loon inﬂation, attempting to better demarcate sampling
location.
Table 1 Sex distribution in the studied patients.
Sex Frequency Percentage
Male 9 81.8
Female 2 18.2
Total 11 100
Table 2 Age distribution in the studied patients.
Mean SD Minimum Maximum
Age 54.4 10.4 42 68
Table 3 Descriptive table shows frequency and percentage of
presenting symptoms in the studied patients.
Symptoms Frequency Percentage
Cough
Yes 10 90.9
Chest pain
Yes 6 54.5
Breathlessness
Yes 3 27.3
Hemoptesis
Yes 9 81.8
Many patients had more than one symptom.
Table 4 Descriptive table shows frequency and percentages of
lesion site.
Site Frequency Percentage
Right upper lobe 4 36.4
Right middle lobe 2 18.2
Right lower lobe 2 18.2
Left upper lobe 2 18.2
Left lower lobe 1 9.1
Table 5 Descriptive table shows frequency and percentage of
diagnostic methods.
Method Frequency Percentage
Bronchoscopic and EBUS guided biopsy 8 72.7
CT guided biopsy 3 27.3
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tilages, spurs and branches which were noted through the
monitor of the EBUS.
EBUS guided-TBNA procedure
After exact site, location and size of the target lymph nodes
and their relation to the tracheobronchial tree were established
the probe was pulled out and the cytological 13-mm-long 22
gauge needle was systemically used for TBNA. Four to six
punctures were performed, beginning with the highest staging
node level in the case. About 4 to 5 specimens were obtained
from the target lymph node and sprayed on slides then ﬁxed
by alcohol and sent to lab for cytological examination.
Cytological examination
All slides were stained by the direct technique, so the aspirate is
immediately placed onto a glass slide, covered with a second
slide spray-ﬁxed by 95% alcohol for 30 min.
– Hematoxylin and Eosin, Periodic acid-Schiff (PAS), Mas-
son’s trichome and Acid- fast stains were used for staining
of slides.
– Stains were left for 15 s-2 min.
– Slides were dehydrated in a graded ethanol series: 50%,
70%, 95% (3 min each) and 100% (3 changes, 3 min each).
– Slides were cleared in a graded xylene or tulene series: 50%
xylene/50% absolute alcohol (3 min); 100%xylene (3
changes, 3 min each).
– Then slides were examined under microscopy.
– If fungal infection was anticipated, special stains as PAS or
papanicolaou stains were used.
Results
Patient data
Sex distribution in the studied patients is shown in Table 1.
Age distribution in the studied patients is shown in Table 2.
All male patients (9) were heavy smokers, while the female
patients (2) were non smokers.
Frequency and percentage of presenting symptoms in the
studied patients are shown in Table 3.
Lesion data
Frequency and percentages of lesion site are shown in Table 4.
Method of diagnosis
Frequency and percentage of diagnostic methods are shown in
Table 5.
Frequency and percentages of histopathological types are
shown in Table 6.Lymph node data
Frequency and percentages of L.N. detected by EBUS and re-
sults by TBNA are shown in Table 7.
Lymph nodes were detected by EBUS in 4 out of 11 cases, 2
cases showed subcarinal and ipsilateralhilar lymph nodes (sta-
tion 7, 10R and 10L). One case showed subcarinal lymph
nodes (station 7) and one case showed ipsilateral hilar lymph
Table 6 Descriptive table shows frequency and percentages of
histopathological types.
Type Frequency Percentage
Adenocarcino-ma 9 81.1
Squamous cell carcinoma 1 9.1
Large cell carcinoma 1 9.1
Table 7 Descriptive table shows frequency and percentages of
L.N. detected by EBUS and results by TBNA.
Frequency Percentage
L.N. stations
7 and 10R 1 9.1
7 and 10L 1 9.1
7 1 9.1
10L 1 9.1
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Diagnostic accuracy (%) of CT for the detection of lymph
nodes=0þ7
11
 100 ¼ 63:6%
Discussion
Accurate staging of lung cancer plays a crucial role with regard
to survival and in determining the treatment options available
to patients with the disease. The preoperative documentation
of metastasis to the mediastinal lymph nodes has therapeutic
implications, that metastasis to the mediastinal lymph nodes
occurs in nearly half of all patients with non small cell lung
cancer [5].
In most centers, computed tomography (CT) of the chest is
the initial method for staging mediastinal lymph nodes. How-
ever, its sensitivity for the detection of metastasis to the lymph
nodes varies; accuracy in previous studies has ranged from
52% to 88% [9].
Endobronchial ultrasonography alone or with ﬁne-needle
aspiration biopsy adds useful diagnostic information in deter-
mining metastasis to mediastinal or hilar lymph nodes in pa-
tients with non-small cell lung cancer [11].
Endobronchial ultrasonography can detect lymph node
metastases and avoid unnecessary surgical exploration in al-
most one of four patients who have no evidence of mediastinal
disease on CT scan [13].
In this study bronchogenic carcinoma was diagnosed by
bronchoscopic biopsy in 6 cases (54.5%), by EBUS-TBNA
in 2 cases (18.2%), and by CT guided biopsy in 3 cases
(27.3%).
Adenocarcinoma was detected in 9 cases (82%). One case
showed squamous cell carcinoma and another large cell
carcinoma(9%).
From the eleven patients with negative CT scan, EBUS of
mediastinal L.N was positive in four cases (36.4%).
EBUS of the ﬁrst case showed 2 small subcarinal L.N sta-
tions (7) measuring (10 · 5.5 mm and 5.3 · 7.7 mm) in diame-
ter and 2 right hilar lymph node stations (10R) measuring
(13.2 · 10.3 mm and 7.5 · 7.5 mm) in diameter.In the second case EBUS detected 2 small subcarinal lymph
node stations (7) measuring (5 · 6 mm), and one left hilar sta-
tion (10L) measuring 10 mm.
In the third case there was one subcarinal lymph node sta-
tion (7) measuring 14 · 12 mm in diameter.
The fourth case also showed one small left hilar lymph node
station (10L) measuring 10 mm in diameter.
In our study the diagnostic accuracy of the CT in detecting
L.N. involvement was 63.6%
These results agree with the study performed by Hiroaki
et al. [7] between July 1996 and April 2003, on 37 patients with
lung cancer in whom 27 patients with no lymph nodes were vis-
ible on their CT scan. In all cases, EBUS added approximately
10 min to the duration of the bronchoscopic procedures.
EBUS carried no particular risk and caused little discomfort.
Lymph node swellings were identiﬁed by EBUS in 9 out of
27 patients with no lymph nodes on their CT scan. Lymph
node 7 was easily identiﬁed and was clearly differentiated from
the surrounding esophagus, vessels, and mediastinal fat tissue
by EBUS. Hilar lymph nodes (10R and 10L) were also ob-
served. Therefore, no lymph node metastasis was described
in this 27 patients using conventional CT as it is very difﬁcult
to differentiate lymph nodes from surrounding vascular struc-
tures on chest CT scans. The accuracy of mediastinal lymph
node metastasis by CT scan was approximately 60% [7].
Also our study agrees with the study performed by Julia
et al. [10] on 72 consecutive patients enrolled during a 3-year
period from September 1997 to August 2002 (46 men and 26
women) between the ages of 33 and 89 (mean 61 years). With
NSCLC and without mediastinal lymphadenopathy on CT,
EBUS altered management in 25% (18 of 72) of patients with
NSCLC without mediastinal lymphadenopathy on CT in
whom mediastinal lymphadenopathy was detected by EBUS
[10].
These results agree also with the study performed by Ann-
ette et al. [1] between May 2000 and August 2001, on the total
number of 33 consecutive patients (23 men and 10 women;
mean age of 61.5 years; age range of 41 to 80 years) of proven
lung cancer. EBUS was an accurate, relatively non invasive,
highly sensitive imaging technique in the detection of lymph
nodes <1 cm, small lymph nodes are more difﬁcult to be de-
tected by CT. The resolution of EBUS may be the reason that
this technique was statistically signiﬁcantly superior to CT [1].
In our study, TBNA was done to 3 out of 4 patients with
positive lymph nodes by EBUS as one patient did not tolerate;
in the 3 cases the cytological examination of TBNA was nega-
tive for malignant cells.
These results disagree with the study performed by Felix
et al. [3] between January 2004 and May 2007, on 97 patients
conﬁrmed to have NSCLC with mean age of 52.9 years. De-
spite negative mediastinal nodes on CT results EBUS-TBNA
of nodes was positive for metastatic disease in 9 patients with
9% prevalence of mediastinal lymph node metastases by
EBUS-TBNA in the present study. The stage changed from
N0 in one patient to stage N3 disease, in ﬁve patients to stage
N2 disease, and in two patients to stage N1disease. All punc-
tures were adequate, and in every smear lymphocytes were vis-
ible. But they reported that, small lymph nodes are difﬁcult to
identify with any imaging modality (including EBUS) and
probably contain a small number of malignant cells, making
a cytological diagnosis difﬁcult. [3].
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lymphadenopathy detected by EBUS right pneumonectomy
with hilar lymph node dissection done, hilar dissection re-
vealed two lymph nodes as detected by EBUS, the larger is
2 · 1 cm. Dissected hilar lymph nodes were sent for histopa-
thological examination which was also negative for malignant
cells as TBNA cytology.
Herth [9] found that EBUS allows visualization of the
tracheobronchial and peribronchial lesions. But there have
been few studies of its efﬁcacy because its use is primarily
limited to specialty centers. Current technology allows for
visualization of airway wall structures and, with ultrasound
penetration of up to 5 cm, permits easy identiﬁcation of lymph
nodes and vessels while only adding a few minutes to the
procedure in experienced hands, and no complication
occurred. In a recent study the technique was used in CT
mediastinal negative patients. Despite the negative CT scans,
EBUS of mediastinal lymph nodes was positive in 17%.
In the present study, although EBUS detected mediastinal
L.N in (36.4%) of CT negative cases, yet the cytological exam-
ination of the TBNA was negative for malignancies and not
conclusive. This is probably because TBNA was performed
blindly after the removal of EBUS because the procedure is
done by a small channel bronchoscope.
Koji et al. [12] found that the main disadvantage of EBUS
guidance using a single-channel bronchoscope is that a
real-time imaging of the needle position within the target lesion
cannot be conﬁrmed because the EBUS probe must be
removed during the TBNA procedure. To overcome this
problem, a double-channel bronchoscope was used, through
which both a TBNA catheter and an EBUS probe, can be
inserted simultaneously.
The detection of lymph nodes 2–4 byEBUSwas occasionally
difﬁcult because of the presence of thick cartilage in the trachea
[7].
Compared with mediastinoscopy, EBUS has the advantage
that it is also able to routinely access posterior mediastinal
(level 7) and hilar lymph nodes (level 10) and that it can be
performed using moderate sedation [9].Conclusion and recommendations
Staging of the lung cancer can be used to guide the patient to-
ward the most appropriate treatment regimen or clinical trial.
The reliability of CT scanning in evaluating mediastinal
node involvement is controversial because of the high false re-
sult rate.
EBUS is a well-established bronchoscope technique but re-
mains underutilized, and the yield varies widely.
EBUS is safe and minimally invasive technique in the detec-
tion of mediastinal lymph metastasis, the complication rate is
extremely low.
EBUS in combination with conventional radiologic tools
may contribute to improve diagnosis and staging.
Double-channel bronchoscope through is better than single
channel to allow direct visualization of the needle placement
and conﬁrms placement of the needle within the target lesion(bronchoscope). This in turn increases the accuracy of the
cytological examination of lymph nodes.
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